Cargando…

P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model

Detalles Bibliográficos
Autores principales: Kobold, S, Steffen, J, Grassmann, S, Castoldi, R, Schmollinger, J, Sustmann, C, Nierderfellner, G, Klein, C, Bourquin, C, Endres, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072107/
http://dx.doi.org/10.1186/2051-1426-2-S2-P42
_version_ 1782322905662619648
author Kobold, S
Steffen, J
Grassmann, S
Castoldi, R
Schmollinger, J
Sustmann, C
Nierderfellner, G
Klein, C
Bourquin, C
Endres, S
author_facet Kobold, S
Steffen, J
Grassmann, S
Castoldi, R
Schmollinger, J
Sustmann, C
Nierderfellner, G
Klein, C
Bourquin, C
Endres, S
author_sort Kobold, S
collection PubMed
description
format Online
Article
Text
id pubmed-4072107
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40721072014-06-27 P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model Kobold, S Steffen, J Grassmann, S Castoldi, R Schmollinger, J Sustmann, C Nierderfellner, G Klein, C Bourquin, C Endres, S J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072107/ http://dx.doi.org/10.1186/2051-1426-2-S2-P42 Text en Copyright © 2014 Kobold et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Kobold, S
Steffen, J
Grassmann, S
Castoldi, R
Schmollinger, J
Sustmann, C
Nierderfellner, G
Klein, C
Bourquin, C
Endres, S
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
title P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
title_full P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
title_fullStr P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
title_full_unstemmed P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
title_short P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model
title_sort p68. a new egfr - epcam bispecific antibody enhances the efficacy of adoptive t-cell therapy in a murine gastric tumour model
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072107/
http://dx.doi.org/10.1186/2051-1426-2-S2-P42
work_keys_str_mv AT kobolds p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT steffenj p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT grassmanns p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT castoldir p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT schmollingerj p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT sustmannc p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT nierderfellnerg p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT kleinc p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT bourquinc p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel
AT endress p68anewegfrepcambispecificantibodyenhancestheefficacyofadoptivetcelltherapyinamurinegastrictumourmodel